Molecular Mechanisms and Pathophysiology of Myocardial Disease: Insights from Pediatric Inflammatory Multisystem

María Teresa Viadero1,2, María Jesús Caldeiro2, Natalia Fernández-Suarez1,2

  • 1Pediatric Cardiology, Division of Pediatrics, University Hospital "Marqués de Valdecilla", University of Cantabria, Avda. Valdecilla s/n, 39008 Santander, Spain.

Insights

Multisystem inflammatory syndrome in children (MIS-C) can cause heart problems. Elevated ferritin and neutrophil-to-lymphocyte ratio (NLR) may indicate ventricular dysfunction in MIS-C patients.

Area of Science:

  • Pediatric Cardiology
  • Immunology
  • Molecular Pathophysiology

Background:

  • Multisystem inflammatory syndrome in children (MIS-C), or pediatric inflammatory multisystem syndrome (PIMS), poses challenges in pediatric cardiology.
  • Its complex molecular pathophysiology requires further investigation, particularly concerning myocardial involvement.

Purpose of the Study:

  • To investigate molecular contributors to myocardial dysfunction in MIS-C.
  • To identify potential prognostic indicators for ventricular dysfunction in pediatric patients.

Main Methods:

  • Retrospective analysis of 15 MIS-C cases managed at a tertiary care center.
  • Evaluation of cytokine storms, hyperinflammation markers, and hypercoagulable states.
  • Analysis of ferritin, NT-ProBNP, troponin, and neutrophil-to-lymphocyte ratio (NLR) in relation to ventricular dysfunction.

Main Results:

  • Transient myocardial involvement occurred in 46.6% of patients, with full recovery.
  • Elevated ferritin, NT-ProBNP, and troponin levels correlated with ventricular dysfunction.
  • Higher NLR was observed in patients with ventricular dysfunction, suggesting prognostic value.
  • No coronary artery aneurysms were detected.

Conclusions:

  • Early, standardized interventions are crucial for mitigating severe outcomes in MIS-C.
  • NLR and ferritin show promise as early indicators for identifying high-risk MIS-C patients with potential cardiac involvement.
  • Understanding molecular mechanisms aids in managing MIS-C-related myocardial dysfunction.

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...